home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 20, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 577 active entries

OctoPlus B.V.

P.O. Box 722
Leiden, 2300 AS, The Netherlands
Netherlands

Phone: +31 (71) 5244044
Fax: +31 (71) 5244043

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

OctoPlus is a Dutch company active in the field of biotechnological and pharmaceutical development with a special expertise in product formulation.
OctoPlus supplies formulation development capacity and drug delivery technology to its clients.
OctoPlus' specialised and proprietary technologies include liposomes, microspheres, protein formulations and non-viral systems for gene delivery.

Services include analytical development and validation, process development, upscaling and optimisation and troubleshooting.

Proprietary technologies are non-viral vectors for gene therapy, biodegradable hydrogels and biodegradable microspheres.

OctoPlus' staff has brought several products to the market/clinic:
- Injectable (recombinant) proteins
- Liposomal formulations
- Solid dosage forms
- Semi-solid dosage forms

For more information, please contact Dr. J.J.M. Holthuis or Prof. Dr. D.J.A. Crommelin.

Selected Categories:

Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Pharmaceutical
- Research
Contract
- Production
- Services

Last update of this entry: June 28, 2004

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.